239 Health claim verifications avg. score 4.4/10 69 rated true or mostly true 169 rated false or misleading
“As of April 2026, treatment advances have made multiple myeloma nearly a curable disease.”
Treatment advances in multiple myeloma are real and significant, but the claim that the disease is "nearly curable" materially overstates the medical consensus as of April 2026. The most authoritative sources — including Memorial Sloan Kettering (January 2026) and Indiana University Cancer Center — explicitly state myeloma remains incurable. Cure-like outcomes such as deep remission and MRD negativity apply only to specific patient subsets under specific regimens, and relapse remains common across the broader population.
“Low testosterone is the primary cause of low libido in men.”
Low testosterone is a well-documented contributor to reduced libido, but no authoritative clinical source identifies it as the "primary" cause. Major medical references — including the Merck Manual, Mayo Clinic, Cleveland Clinic, and the Endocrine Society — consistently describe male libido as multifactorial, with psychological factors (depression, anxiety, relationship problems), medications, chronic conditions, and lifestyle factors frequently playing equal or greater roles. The claim conflates testosterone's important role with singular primacy, an assertion the clinical evidence does not support.
“Maca root is scientifically proven to boost libido in humans.”
The phrase "scientifically proven" significantly overstates what the evidence actually shows. While several small randomized controlled trials have found statistically significant improvements in sexual desire with maca root, the systematic reviews synthesizing this research explicitly conclude the evidence is "too limited to draw firm conclusions." Positive findings are confined to specific subpopulations, sample sizes are small, and no large confirmatory trials exist — falling well short of the robust consensus implied by "proven."
“Zinc supplementation increases testosterone levels and improves sexual performance in men.”
Zinc supplementation can raise testosterone — but primarily in men who are already zinc-deficient, not men generally. The claim's universal framing omits this critical qualifier, which is consistently emphasized across the strongest peer-reviewed evidence, including a 2022 systematic review of 38 studies. The "sexual performance" sub-claim relies almost entirely on animal studies involving lead-exposed rats, with no robust human clinical trial demonstrating this benefit in typical men. A large multicenter human RCT found no reproductive improvement and even documented harm from zinc supplementation.
“Having sex at least once a week produces measurable improvements in physical and mental health outcomes.”
Weekly sexual activity is associated with some better mental health markers in certain populations, but the claim overstates the evidence by using causal language ("produces") when the research is largely observational and correlational. A major systematic review flags contradictory findings, confounding bias, and population-specific effects. Physical health benefits are inconsistently supported — some longitudinal data actually links higher sexual frequency to increased cardiovascular risk in older men. The evidence does not support a blanket causal claim across both physical and mental health.
“The bacterium Prevotella copri is classified as a pathogen.”
Prevotella copri is not formally classified as a pathogen by any authoritative taxonomic or regulatory body. The gold-standard bacterial nomenclature registry LPSN assigns it to Risk Group 1, meaning it is "unlikely to cause human disease." While certain strains have shown disease associations — particularly with rheumatoid arthritis — the scientific literature consistently describes P. copri as a commensal or "pathobiont" with strain-dependent effects, not a pathogen. The claim conflates pathogenic potential in specific contexts with a formal species-wide classification that does not exist.
“Red yeast rice lowers cholesterol levels in humans.”
Clinical evidence strongly supports that red yeast rice preparations containing meaningful amounts of monacolin K lower LDL and total cholesterol in humans, with meta-analyses of randomized controlled trials showing 15–25% LDL reductions. However, the claim requires an important caveat: monacolin K content varies widely across commercial products, and in the U.S., products with substantial monacolin K face FDA restrictions as unapproved drugs. Not all retail red yeast rice supplements will reliably produce cholesterol-lowering effects.
“The oral contraceptive pill universally reduces sexual desire in all women who take it.”
The evidence decisively contradicts this claim. Systematic reviews show approximately 84.6% of oral contraceptive users report no change in sexual desire, and about 12% actually report an increase — only a small minority experience a decrease. While reduced libido is a real, documented side effect for some women, the claim's absolute language — "universally" and "all women" — is unsupported by any credible source. The pill's effects on desire are highly variable and individual.
“Use of the oral contraceptive pill causes long-term or permanent infertility after discontinuation.”
Overwhelming medical evidence directly contradicts this claim. The World Health Organization, systematic reviews, and large cohort studies all confirm that oral contraceptive use — regardless of duration — does not cause long-term or permanent infertility, with fertility returning promptly after discontinuation. Some women may experience temporary cycle irregularity, but this is a short-term adjustment, not infertility. The sources cited in support of the claim are either low-authority, commercially conflicted, or internally self-contradictory.
“Consumption of walnuts can improve sperm quality in humans.”
Peer-reviewed randomized controlled trials consistently show that walnut consumption produces statistically significant improvements in measurable sperm parameters including motility, vitality, and morphology. The evidence firmly supports the claim as stated — about sperm quality, not fertility outcomes. However, no large-scale study has confirmed these improvements translate to higher pregnancy or live-birth rates, and the primary RCT studied men on a Western-style diet, limiting generalizability.
“High-protein diets do not cause kidney damage in people with healthy kidneys.”
The best available evidence — including a major systematic review and meta-analysis — shows that high-protein diets have not been demonstrated to harm kidney function in healthy adults over studied timeframes. However, the claim's absolute phrasing ("do not cause kidney damage") overstates what the science can confirm. Most supporting trials are short-to-medium term, long-term effects remain uncertain, and some observational data and mechanistic concerns (hyperfiltration, kidney stones) complicate a categorical safety guarantee.
“A blood test developed by researchers at the University of East Anglia can detect early-stage dementia with 79% accuracy.”
The 79% accuracy figure is real but significantly mischaracterized. UEA researchers developed a preliminary machine-learning model using six gut-derived blood metabolites that classifies participants across three study groups — healthy, mild cognitive impairment (MCI), and impaired — with 79% accuracy. This is not a validated clinical blood test, and MCI is a precursor state, not equivalent to "early-stage dementia." Even UEA-affiliated coverage describes the work as research that "could pave the way" for a future test, not a deployable diagnostic tool.
“Common cosmetic ingredients, when used at regulatory-approved doses, are toxic to human health.”
The evidence does not support the assertion that common cosmetic ingredients are toxic at regulatory-approved doses. Regulatory frameworks in the EU, Canada, and (post-MoCRA) the U.S. set approved doses well below observed adverse-effect thresholds, typically with 100x safety margins. Sources cited in support describe associations at unspecified exposure levels, regulatory gaps, or scientific uncertainty about long-term cumulative effects — none demonstrate toxicity at approved doses under normal use. The claim conflates hazard identification with actual risk at regulated exposure levels.
“Dietary intervention is more effective than medication at reversing coronary artery disease.”
While intensive lifestyle programs have demonstrated some angiographic regression of coronary artery disease, no rigorous head-to-head trial has compared dietary intervention against modern statin or PCSK9-inhibitor therapy for CAD reversal. The landmark Lifestyle Heart Trial (n=48) lacked a medication arm and tested a multi-component program—not diet alone. High-quality reviews indicate that combining lifestyle changes with medication produces the best outcomes, undermining the claim that diet is "more effective" than drugs.
“Eliminating carbohydrates from the diet causes fat loss regardless of total caloric intake.”
Controlled metabolic-ward studies consistently show that when calories are held equal, eliminating carbohydrates does not produce superior fat loss — and in some cases, fat restriction outperforms carbohydrate restriction. While low-carb diets can aid weight loss in real-world settings, this effect is largely driven by spontaneous calorie reduction through appetite suppression, not a calorie-independent mechanism. The claim's absolute framing — "regardless of total caloric intake" — contradicts the established scientific principle that a caloric deficit is required for fat loss.
“Insulin resistance prevents fat loss in humans.”
The absolute claim that insulin resistance "prevents" fat loss is not supported by the evidence. High-authority mechanistic studies show insulin resistance preserves antilipolytic signaling, making fat loss harder — but multiple clinical studies demonstrate that insulin-resistant individuals do lose fat through caloric restriction and exercise, sometimes at rates equal to or exceeding non-insulin-resistant groups. The accurate statement is that insulin resistance impedes or complicates fat loss, not that it categorically blocks it.
“Elevated cortisol levels do not directly prevent fat loss in humans.”
This claim oversimplifies a highly context-dependent biological relationship. While cortisol can stimulate fat mobilization under certain acute conditions, peer-reviewed evidence shows that under chronic elevation — when insulin is typically co-elevated — cortisol promotes fat storage via lipoprotein lipase activation and reduces basal lipolysis. The blanket assertion that elevated cortisol "does not directly prevent fat loss" omits these critical mechanistic distinctions, leaving readers with a materially incomplete picture.
“A declassified Central Intelligence Agency document reveals the existence of a cancer cure that has been suppressed.”
The declassified memo discusses 1950 Soviet lab work; it does not document a proven cancer cure, nor was it hidden—files have been publicly available for years. No credible evidence supports a suppressed, definitive cure.
“Manual therapy is an effective, evidence-based practice that provides long-term treatment benefits.”
Manual therapy is recognized in clinical guidelines, but primarily as a short-term adjunct within multimodal care — not as a standalone treatment with durable long-term benefits. Multiple umbrella reviews and systematic reviews show that MT's effects tend to diminish over time, losing statistical significance by 13–52 weeks. Methodological concerns — including difficulty with blinding, inadequate controls, and short follow-up periods — may also inflate apparent effectiveness. The claim's assertion of "long-term treatment benefits" is not supported by the weight of current evidence.
“Exposure therapy is considered one of the most effective treatments for phobias.”
This claim is well-supported. Major health authorities — including the NHS, WHO, Mayo Clinic, APA, and the Australian Psychological Society — all independently identify exposure therapy as one of the most effective and best-evidenced treatments for phobias. Mayo Clinic calls it "the best treatment" for specific phobias, and the Australian Psychological Society notes it has "the most research evidence." The claim's careful phrasing ("considered one of the most effective") accurately reflects the established clinical consensus.